F/m Emerald Life Sciences Innovation ETF LFSC
44.90 USD +1.53 (+3.53%)
At closeNov 6, 2026, 4:00 PM EST
44.90 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
43.57 Day range 44.90
32.84 52-week range 48.78
- YTD
- +22.62%
- 1 year
- +43.37%
News
benzinga.com Spyre Therapeutics Breaks Higher On Positive Data From Ulcerative Colitis Drug Spyre Therapeutics stock jumps after Phase 2 SKYLINE data; SPY001 shows efficacy in ulcerative colitis as analysts maintain bullish outlook.
benzinga.com Cogent Biosciences Stock Climbs After FDA Accepts Key Drug Application FDA accepts Cogent Biosciences' NDA for bezuclastinib in NonAdvSM. PDUFA date set for Dec 30, 2026. COGT stock rises on the news.
benzinga.com Travere Stock Slips After FDA Delays Review Of Key Kidney Drug Travere Therapeutics' stock declines as FDA extends review of key kidney drug. Q4 sales forecast at $127 million.
benzinga.com This New ETF Doesn't Wait For Stability — It Profits From Disruption This ETF dives into overlooked corners of the market, betting on catalysts such as M&A, regulatory shifts and corporate turnarounds.